Volume 11, Number 12—December 2005
Research
Viral Load Distribution in SARS Outbreak
Table
Factor | E block patients (n = 53) | Non-E block patients (n = 26) | p value |
---|---|---|---|
Age, y, mean (SD) | 40.6 (11.9) | 37.1 (10.6) | 0.21† |
Male:female ratio | 25:28 | 13:13 | 0.81‡ |
Duration of symptoms to admission (days), mean (SD) | 2.4 (1.2) | 2.5 (1.2) | 0.72† |
Coexisting conditions including chronic hepatitis B, no. (%) | 11 (19.6) | 8 (30.8) | 0.33‡ |
Chronic hepatitis B infection, no. (%) | 5 (9.4) | 5 (19.2) | 0.22‡ |
Abnormal chest radiograph results, no. (%) | 38 (71.7) | 21 (80.8) | 0.38‡ |
Multilobar involvement on initial chest radiograph, no. (%) | 13 (24.5) | 5 (19.2) | 0.60‡ |
Day of collection of nasopharyngeal specimens after onset of symptoms, mean (SD) | 3.2 (1.2) | 3.3 (1.8) | 0.74† |
Quantitative RT-PCR result of nasopharyngeal specimens (log10 copies/mL), median (IQR) | 5.09 (3.50–6.59) | 0 (0–3.57) | 0.008§ |
Hemoglobin (g/dL), mean (SD) | 13.3 (1.7) | 13.8 (1.4) | 0.24† |
Neutrophil count (× 109/L), mean (SD) | 5.2 (2.0) | 5.3 (2.0) | 0.77† |
Lymphocyte count (× 109/L), mean (SD) | 0.92 (0.6) | 0.86 (0.4) | 0.65† |
Sodium (mmol/L), mean (SD) | 138 (3) | 138 (3) | 0.91† |
Potassium (mmol/L), mean (SD) | 3.9 (3.6) | 3.9 (3.0) | 0.31† |
Urea (mmol/L), mean (SD) | 4.4 (1.4) | 4.1 (1.0) | 0.34† |
Creatinine (μmol/L), mean (SD) | 88 (16) | 85 (12) | 0.35† |
Alanine aminotransferase (IU/L), mean (SD) | 41 (49) | 31 (19) | 0.31† |
Albumin (g/L), mean (SD) | 40 (3) | 40 (3) | 0.85† |
Creatinine kinase (IU/L), mean (SD) | 197 (222) | 190 (186) | 0.89† |
Lactate dehydrogenase (IU/L), mean (SD) | 437 (190) | 398 (107) | 0.47† |
*SD, standard deviation; IQR, interquartile ratio; RT-PCR, reverse transcription–polymerase chain reaction.
†By Student t test.
‡By chi-square test.
§By Mann-Whitney U test.
Page created: February 02, 2012
Page updated: February 02, 2012
Page reviewed: February 02, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.